Hanna Cholewa

Hanna Cholewa

Auto-generated profile, based on publicly available information

Hanna Cholewa

Department of Colorectal Surgery, University and Polytechnic Hospital La Fe, Valencia, Spain

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2024 in International Journal of Colorectal Disease
Verified
Journal Article
Open access
PDF file
JSJorge Sancho-Muriel
Jorge Sancho-Muriel
HCHanna Cholewa
Hanna Cholewa
MMMónica Millán
Mónica Millán
DQDavid Quevedo
David Quevedo
EAEduardo Alvarez-Sarrado
Eduardo Alvarez-Sarrado
BFBlas Flor-Lorente
Blas Flor-Lorente
Purpose: The main aim of this study was to determine the short- and long-term outcomes of the non-operative management of acute left-sided complicated diverticulitis (ALCD) in severely immunocompromised patients (IMS group) and compare them with immunocompetent patients (IC group). The secondary aim was to assess the necessity of an elective surgery following a successful prior non-operative management in the IMS group after a non-operative management of the first episode of ALCD. Methods: Patients presented with their first episode of ALCD between 2012 and 2018 were retrospectively reviewed. Only severely immunosuppressed patients were considered for the analysis, including the following: long-term oral or intravenous steroid intake, current malignancy undergoing chemotherapy, chronic kidney disease on hemodialysis, or solid organ transplant with immunosuppressive medication. For each group, demographic data, severity of the episode, management decisions (conservative or operative), and short- and long-term outcomes were recorded and compared. A sub-analysis of patients with ALCD associating and abscess (modified Hinchey classification Ib/II) was performed. Results: A total of 290 patients were included in the study: 50 among the IMS and 240 among the IC group. The rate of emergent surgery was higher in the IMS group (50.0% vs. 22.5%, p < 0.001) and was associated with increased morbidity (72.4% vs. 50.0%, p = 0.041) and mortality (24.1% vs. 4.3%, p = 0.003). The duration of the hospital stay was significantly longer in the IMS group (15 vs. 8 days, p < 0.001). The final stoma rate was significantly higher in the IMS group (82.1% vs. 22.9, p < 0.001), with a median follow-up of 51.4 months. A total of 141 patients presented ALCD with an abscess; 25 in the IMS and 116 in the IC group. There was a higher rate of surgical intervention among the IMS group as the initial treatment approach (24.0% vs. 5.2%, p = 0.002), even though the conservative treatment had a similar rate of success (81.3% vs. 92.0%, p = 0.178). The recurrence rate following a non-operative approach was similar (IMS: 31.2% vs. 35.4% in the IC group, p = 0.169). Furthermore, 81.2% of non-operatively managed IMS patients (13 out of 16) did not require a surgical intervention at the end of the follow-up, with similar findings in the IC group (78/96, 81.2%, p = 0.148). Conclusion: Medical treatment of immunosuppressed patients during their first ALCD episode associated with an abscess is feasible, with a high success rate and results comparable with the IC group. Moreover, taking into account the readmission rates, the need for emergent surgery of the recurrence, and the perioperative mortality and morbidity in the IMS group, conservative management with no differed scheduled surgery seems to be a safe option in this subgroup of patients.

31 August 2023 in Diseases of the Colon & Rectum
Verified
Journal Article
Closed access
HCHanna Cholewa
Hanna Cholewa
JSJorge M.D. Sancho-Muriel
Jorge M.D. Sancho-Muriel
BFBlas M.D. Flor-Lorente
Blas M.D. Flor-Lorente
An abstract is unavailable. This article is available as a PDF only.

25 March 2020 in Colorectal Disease
Verified
Journal Article
Closed access
PDF file
JSJorge Sancho‐Muriel
Jorge Sancho‐Muriel
HCHanna Cholewa
Hanna Cholewa
VPVicent Primo-Romaguera
Vicent Primo-Romaguera
ÁGÁlvaro García‐Granero
Álvaro García‐Granero
MMMonica Millán
Monica Millán
MFMatteo Frasson
Matteo Frasson

21 February 2023 in Colorectal Disease
Verified
Journal Article
Closed access
VPVicent Primo-Romaguera
Vicent Primo-Romaguera
DLDavid Plazas López
David Plazas López
EÁEduardo Álvarez‐Sarrado
Eduardo Álvarez‐Sarrado
JSJorge Sancho‐Muriel
Jorge Sancho‐Muriel
HCHanna Cholewa
Hanna Cholewa
MMMonica Millan
Monica Millan

1 March 2024 in Colorectal Disease
Verified
Journal Article
Closed access
MFMarcello Filotico
Marcello Filotico
JSJorge Sancho‐Muriel
Jorge Sancho‐Muriel
HCHanna Cholewa
Hanna Cholewa
MFMatteo Frasson
Matteo Frasson
RCRoberto Adriano Castro
Roberto Adriano Castro
BFBlas Flor‐Lorente
Blas Flor‐Lorente

10 May 2025 in International Journal of Colorectal Disease
Verified
Journal Article
Open access
PDF file
EAEduardo Alvarez-Sarrado
Eduardo Alvarez-Sarrado
MFMatteo Frasson
Matteo Frasson
JSJorge Sancho-Muriel
Jorge Sancho-Muriel
MGMaria Jose Gomez-Jurado
Maria Jose Gomez-Jurado
HCHanna Cholewa
Hanna Cholewa
FGFrancisco Giner
Francisco Giner
Purpose: To assess the relevance of peritoneal reflection involvement in long-term oncological outcomes in patients with rectal cancer. Methods: Prospective observational study from a specialized colorectal unit that included a consecutive series of patients undergoing mesorectal excision for rectal cancer. Peritoneal reflection (PR) involvement was evaluated on pathological examination using Shepherd’s classification. Overall survival (OS), disease-free survival (DFS), and local recurrence (LR) were assessed. Results: One hundred sixty patients were included in the present analysis. Peritoneal involvement was present in 28.2% of the 85 tumors above or at the level of PR. There were no differences in OS, DFS, or LR according to tumor’s height location. The 5-year OS, DFS, and LR for tumors involving PR were 58.3%, 61.7%, and 30.3%, respectively. Patients with peritoneal involvement had a higher LR rate (p = 0.02) and shorter OS (p = 0.04). Shepherd’s grade 4 peritoneal involvement was an independent risk factor for OS (HR 2.9; 95% CI 1.1–9.5, p = 0.04) and LR (HR 4.2; 95% CI 1.2–16.9, p = 0.04). Conclusion: After rectal cancer resection, peritoneal involvement is an independent risk factor for local recurrence and poor survival.